Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Sensor Patch Accurately Detects Atrial Fibrillation

By HospiMedica International staff writers
Posted on 24 Nov 2021
An easy-to-use long-term electrocardiogram (ECG) sensor allows continuous outpatient recording of heart rhythms, with the diagnostic accuracy of a Holter monitor.

The Appsens AS (Lillesand, Norway) ECG247 heart sensor is a wireless single-lead ECG monitor that consists of an electrode patch with a lightweight reusable sensor, a smartphone application, a back-end cloud service, and a web portal. More...
The water-resistant sensor attaches over the sternum and continuously monitors heart rhythm for up to 14 days without the need for charging. All ECG recordings are sent via Bluetooth Low Energy (BLE) communication through an app on the patient’s mobile phone to secure Microsoft Azure cloud storage, with web-access for the user and for healthcare professionals.

The ECG247 algorithms automatically detect and categorize cardiac arrhythmias using a multiple-step algorithm that analyzes the QRS complex as an adaptive process to ensure reliable detection; identify the correct beat type, based on a machine-learning algorithm that distinguishes between normal beats, supraventricular beats, ventricular beats, and artefacts; and analyze the arrhythmias or changes in rhythm to detect atrial flutter (AF), low/high heart rate, supraventricular tachycardia, ventricular tachycardia, and pauses.

“By detecting heart rhythm disorders early, ECG247 can help prevent serious complications such as stroke; 50,000 people [in Norway] with heart fibrillation are not aware of this because they have no symptoms,” said Tord Ytterdahl, managing director of Appsens AS. “At the moment, there is no product with the right technology that captures the large group of people who have this. Many people who feel palpitations from time to time can now easily test themselves.”

The original Holter monitor, named for physicist Norman J. Holter who invented telemetric cardiac monitoring in 1949, is a portable device for continuously monitoring various electrical activity of the cardiovascular system for at least 24 hours (often for two weeks at a time). Its extended recording period is useful for observing occasional cardiac arrhythmias which would be difficult to identify in a shorter period of time.

Related Links:
Appsens AS


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.